Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malte Kircher

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2019
Imaging Inflammation in Atherosclerosis with CXCR4-Directed <sup>68</sup>Ga-Pentixafor PET/CT: Correlation with <sup>18</sup>F-FDG PET/CTMalte Kircher, Johannes Tran-Gia, Luisa Kemmer, et al.
Theranostics|January 8, 2019
The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?Rudolf A Werner, Alexander Weich, Malte Kircher, et al.
Clinical Nuclear Medicine|August 2, 2024
Biodistribution and Radiation Dosimetry for 68 Ga-DOTA-CCK-66, a Novel CCK 2 R-Targeting Compound for Imaging of Medullary Thyroid CancerOliver Viering, Andreas Rinscheid, Nadine Holzleitner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2018
Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell LymphomaConstantin Lapa, Heribert Hänscheid, Malte Kircher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2025
Biodistribution and Radiation Dosimetry of [<sup>68</sup>Ga]Ga-RAYZ-8009, a Glypican 3-Targeting Compound for Imaging of Hepatocellular CarcinomaOliver Viering, Julia Brosch-Lenz, Ralph A Bundschuh, et al.
Clinical Nuclear Medicine|April 7, 2021
Peptide Receptor Radionuclide Therapy in Patients With Neurofibromatosis Type 2: Initial ExperienceOlivia Kertels, Maria Breun, Heribert Hänscheid, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|July 6, 2022
[<sup>18</sup>F]FDG-PET/CT improves the detection of synchronous malignancies at primary staging of oral squamous cell carcinoma - A retrospective studyChristian Linz, Roman C Brands, Stephan Hackenberg, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Molecular Imaging in Multiple Myeloma-Novel PET Radiotracers Improve Patient Management and Guide TherapyJohannes von Hinten, Malte Kircher, Alexander Dierks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2024
Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and EfficacyAdriana Amerein, Christoph Maurer, Malte Kircher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 2, 2024
First Safety and Efficacy Data with the Radiohybrid <sup>177</sup>Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate CancerAlexander Dierks, Alexander Gäble, Andreas Rinscheid, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2019
Imaging Inflammation in Atherosclerosis with CXCR4-Directed <sup>68</sup>Ga-Pentixafor PET/CT: Correlation with <sup>18</sup>F-FDG PET/CTMalte Kircher, Johannes Tran-Gia, Luisa Kemmer, et al.
Theranostics|January 8, 2019
The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?Rudolf A Werner, Alexander Weich, Malte Kircher, et al.
Clinical Nuclear Medicine|August 2, 2024
Biodistribution and Radiation Dosimetry for 68 Ga-DOTA-CCK-66, a Novel CCK 2 R-Targeting Compound for Imaging of Medullary Thyroid CancerOliver Viering, Andreas Rinscheid, Nadine Holzleitner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2018
Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell LymphomaConstantin Lapa, Heribert Hänscheid, Malte Kircher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2025
Biodistribution and Radiation Dosimetry of [<sup>68</sup>Ga]Ga-RAYZ-8009, a Glypican 3-Targeting Compound for Imaging of Hepatocellular CarcinomaOliver Viering, Julia Brosch-Lenz, Ralph A Bundschuh, et al.
Clinical Nuclear Medicine|April 7, 2021
Peptide Receptor Radionuclide Therapy in Patients With Neurofibromatosis Type 2: Initial ExperienceOlivia Kertels, Maria Breun, Heribert Hänscheid, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|July 6, 2022
[<sup>18</sup>F]FDG-PET/CT improves the detection of synchronous malignancies at primary staging of oral squamous cell carcinoma - A retrospective studyChristian Linz, Roman C Brands, Stephan Hackenberg, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Molecular Imaging in Multiple Myeloma-Novel PET Radiotracers Improve Patient Management and Guide TherapyJohannes von Hinten, Malte Kircher, Alexander Dierks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2024
Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and EfficacyAdriana Amerein, Christoph Maurer, Malte Kircher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 2, 2024
First Safety and Efficacy Data with the Radiohybrid <sup>177</sup>Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate CancerAlexander Dierks, Alexander Gäble, Andreas Rinscheid, et al.
Pageof 6